已更新
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
传染病学 2025医学知识库
临床指南
查阅医学学会和卫生主管部门发布的官方指南、共识文件及更新信息。
官方可靠来源医学学会和卫生主管部门
信息持续更新持续开展科学监测
面向专业人士免费开放服务于医学界
重要出版物和更新
查看最新发布内容
已更新
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
心脏病学 2025
官方发布
WHO guidelines on the integrated management of obesity in adolescents
World Health Organization
儿科学 2026所有指南 (524 个结果)
筛选条件
Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]”. NACI recomme...
Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax CO...
Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6...
Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID...
Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]”. NACI i...
Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID...
Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]”. NACI up...
Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron...
Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]”...
Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a...